Barely Significant
← all excerpts

Effect of co-administration of rivaroxaban and clopidogrel on bleeding time, pharmacodynamics and pharmacokinetics: a phase I study.

Pharmaceuticals (Basel) · 2012 · PMC3763640 · PMID 24281379

1
hedged sentence
closest p
boldest claim

The sentences

borderline significantno p-value reported
These data indicate that monotherapy with rivaroxaban had no relevant effect on bleeding time and monotherapy with clopidogrel had only a borderline significant effect (two-fold increase in bleeding time).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.